Zobrazeno 1 - 10
of 251
pro vyhledávání: '"Apostolos Armaganidis"'
Autor:
Irene Karampela, Natalia G. Vallianou, Dimitrios Tsilingiris, Gerasimos Socrates Christodoulatos, Georgios Antonakos, Ioanna Marinou, Evaggelos Vogiatzakis, Apostolos Armaganidis, Maria Dalamaga
Publikováno v:
Medicina, Vol 59, Iss 5, p 833 (2023)
Background and Objectives: Omentin-1, also known as intelectin-1, is a novel adipokine with anti-inflammatory activities implicated in inflammatory diseases and sepsis. We aimed to explore serum omentin-1 and its kinetics in critically ill patients e
Externí odkaz:
https://doaj.org/article/498269c7c3304c529087a3d18ec68fc0
Autor:
Marianna Miliaraki, Panagiotis Briassoulis, Stavroula Ilia, Aikaterini Polonifi, Marina Mantzourani, Efrossini Briassouli, Konstantinos Vardas, Serafim Nanas, Aikaterini Pistiki, Maria Theodorakopoulou, Theonymfi Tavladaki, Anna Maria Spanaki, Eumorfia Kondili, Helen Dimitriou, Sotirios Tsiodras, Dimitrios Georgopoulos, Apostolos Armaganidis, George Daikos, George Briassoulis
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Sepsis is a dysregulated host response to infection related to devastating outcomes. Recently, interest has been shifted towards apoptotic and antiapoptotic pathobiology. Apoptosis is executed through the activation of caspases regulated by
Externí odkaz:
https://doaj.org/article/a0ed4e1ae2ca416b9c061d113cc6a5a2
Autor:
Dimitrios Velissaris, George Dimopoulos, John Parissis, Zoi Alexiou, Nikolaos Antonakos, Dimitrios Babalis, Styliani Gerakari, Vassileios Kaldis, Pantelis Koutoukas, Malvina Lada, Konstantinos Leventogiannis, Ioannis Pantazopoulos, Antonios Papadopoulos, Eftihia Polyzogopoulou, Charalambos Gogos, Apostolos Armaganidis, Evangelos J. Giamarellos-Bourboulis
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 3, Pp 407-416 (2020)
Abstract In light of the accumulating evidence on the negative predictive value of soluble urokinase plasminogen activator receptor (suPAR), a group of experts from the fields of intensive care medicine, emergency medicine, internal medicine and infe
Externí odkaz:
https://doaj.org/article/b07ac0cd21e043a69ac0d5ee1bff23d1
Autor:
Anastasia Anthi, Dimitrios Tsiapras, Panagiotis Karyofyllis, Vassilios Voudris, Apostolos Armaganidis, Stylianos E. Orfanos
Publikováno v:
Pulmonary Circulation, Vol 11 (2021)
Pulmonary hypertension (PH) development remains a significant cardiovascular complication of haemoglobinopathies, severely affecting the morbidity and mortality of such patients. According to the 5th World Symposium on PH, PH related with chronic hae
Externí odkaz:
https://doaj.org/article/6f5fb2a5236e43e78cdbc3d3abdae78b
Autor:
Helen Triantafyllidi, Olympia Apostolopoulou, Dimitris Benas, Ignatios Ikonomidis, Mary Varoudi, Iraklis Tsagkaris, Anastasia Anthi, Loukianos Rallidis, Dimitrios Kostantonis, Frantzeska Frantzeskaki, George Pavlidis, Leonidas Palaiodimos, Antonios Schoinas, Apostolos Armaganidis, John Lekakis, Stylianos E. Orfanos
Publikováno v:
Hellenic Journal of Cardiology, Vol 61, Iss 4, Pp 288-290 (2020)
Externí odkaz:
https://doaj.org/article/cfb025098ebd49a0a6eb51b87420e427
Autor:
Constantinos Pantos, Georgia Kostopanagiotou, Apostolos Armaganidis, Athanasios Trikas, Ioulia Tseti, Iordanis Mourouzis
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-3 (2020)
Abstract Objectives Tissue hypoxia is the main cause of multi-organ dysfunction in sepsis. However, effective pharmacological treatments to combat sepsis-induced tissue hypoxia are not available. Emerging experimental and clinical evidence reveals an
Externí odkaz:
https://doaj.org/article/e7b54b9c04ab4fa19c2d52dacd9a9a78
Autor:
Anastasia Anthi, Eleni Stagaki, Loukianos Rallidis, Dimitrios Konstantonis, Maria-Eleftheria Evangelopoulos, Konstantinos Voumvourakis, Apostolos Armaganidis, Stylianos E. Orfanos
Publikováno v:
ERJ Open Research, Vol 6, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/f6dc968e6e6a466baacdd0eaf4eda2ba
Autor:
Irene Karampela, Gerasimos Socrates Christodoulatos, Natalia Vallianou, Dimitrios Tsilingiris, Evangelia Chrysanthopoulou, George Skyllas, Georgios Antonakos, Ioanna Marinou, Evaggelos Vogiatzakis, Apostolos Armaganidis, Maria Dalamaga
Publikováno v:
Biomolecules, Vol 12, Iss 2, p 301 (2022)
Chemerin, a novel adipokine, is a potent chemoattractant molecule with antimicrobial properties, implicated in immune responses. Our aim was to investigate circulating chemerin and its kinetics, early in sepsis in critically ill patients and its asso
Externí odkaz:
https://doaj.org/article/f052898ad29541c0af757f44675bf099
Autor:
Marianna Miliaraki, Panagiotis Briassoulis, Stavroula Ilia, Kalliopi Michalakakou, Theodoros Karakonstantakis, Aikaterini Polonifi, Kalliopi Bastaki, Efrossini Briassouli, Konstantinos Vardas, Aikaterini Pistiki, Maria Theodorakopoulou, Theonymfi Tavladaki, Anna-Maria Spanaki, Eumorfia Kondili, Helen Dimitriou, Maria Venihaki, Sotirios Tsiodras, Dimitrios Georgopoulos, Marina Mantzourani, Serafeim Nanas, Apostolos Armaganidis, George L. Daikos, Ioannis Papassotiriou, George Briassoulis
Publikováno v:
Antioxidants, Vol 11, Iss 2, p 231 (2022)
Oxidative stress is considered pivotal in the pathophysiology of sepsis. Oxidants modulate heat shock proteins (Hsp), interleukins (IL), and cell death pathways, including apoptosis. This multicenter prospective observational study was designed to as
Externí odkaz:
https://doaj.org/article/f7a9bcd4c64e4abebbff5bbc3bf187cb
Autor:
Evdoxia Kyriazopoulou, Konstantinos Leventogiannis, Anna Norrby-Teglund, Georgios Dimopoulos, Aikaterini Pantazi, Stylianos E. Orfanos, Nikoletta Rovina, Iraklis Tsangaris, Theologia Gkavogianni, Elektra Botsa, Eleftheria Chassiou, Anastasia Kotanidou, Christina Kontouli, Panagiotis Chaloulis, Dimitrios Velissaris, Athina Savva, Jonas-Sundén Cullberg, Karolina Akinosoglou, Charalambos Gogos, Apostolos Armaganidis, Evangelos J. Giamarellos-Bourboulis, on behalf of the Hellenic Sepsis Study Group
Publikováno v:
BMC Medicine, Vol 15, Iss 1, Pp 1-10 (2017)
Abstract Background A subanalysis of a randomized clinical trial indicated sepsis survival benefit from interleukin (IL)-1 blockade in patients with features of the macrophage activation-like syndrome (MALS). This study aimed to investigate the frequ
Externí odkaz:
https://doaj.org/article/0212585c0a184560bf60ae526a894911